Importin 7 may be dispensable for human immunodeficiency virus type 1 and simian immunodeficiency virus infection of primary macrophages
| dc.contributor.author | Zielske, Steven P. | |
| dc.contributor.author | Stevenson, Mario | |
| dc.date | 2022-08-11T08:09:34.000 | |
| dc.date.accessioned | 2022-08-23T16:35:52Z | |
| dc.date.available | 2022-08-23T16:35:52Z | |
| dc.date.issued | 2005-08-17 | |
| dc.date.submitted | 2009-03-26 | |
| dc.identifier.citation | J Virol. 2005 Sep;79(17):11541-6. <a href="http://dx.doi.org/10.1128/JVI.79.17.11541-11546.2005">Link to article on publisher's site</a> | |
| dc.identifier.issn | 0022-538X (Print) | |
| dc.identifier.doi | 10.1128/JVI.79.17.11541-11546.2005 | |
| dc.identifier.pmid | 16103209 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14038/38659 | |
| dc.description.abstract | In an in vitro assay employing reconstituted nuclei, importin 7 (IPO7) has been implicated in nuclear translocation of human immunodeficiency virus type 1 (HIV-1) cDNA. Using RNA interference technology, we inhibited expression of IPO7 by 80 to 95% in primary macrophages and in HeLa cells and monitored their ability to support HIV-1 and simian immunodeficiency virus (SIV) cDNA synthesis, nuclear translocation, and infection efficiency. Marked IPO7 deficiency did not alter the rate or extent of HIV-1 or SIV cDNA synthesis or nuclear translocation. The infection efficiency of HIV-1 was similarly unaltered. Therefore, in natural, nondividing targets of HIV-1, IPO7 may be dispensable for infection. | |
| dc.language.iso | en_US | |
| dc.relation | <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=16103209&dopt=Abstract">Link to Article in PubMed</a> | |
| dc.subject | Cells, Cultured | |
| dc.subject | Gene Expression Regulation, Viral | |
| dc.subject | HIV Infections | |
| dc.subject | HIV-1 | |
| dc.subject | Hela Cells | |
| dc.subject | Humans | |
| dc.subject | Karyopherins | |
| dc.subject | Macrophages | |
| dc.subject | Simian Acquired Immunodeficiency Syndrome | |
| dc.subject | Simian immunodeficiency virus | |
| dc.subject | Life Sciences | |
| dc.subject | Medicine and Health Sciences | |
| dc.title | Importin 7 may be dispensable for human immunodeficiency virus type 1 and simian immunodeficiency virus infection of primary macrophages | |
| dc.type | Journal Article | |
| dc.source.journaltitle | Journal of virology | |
| dc.source.volume | 79 | |
| dc.source.issue | 17 | |
| dc.identifier.legacyfulltext | https://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=2516&context=oapubs&unstamped=1 | |
| dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/oapubs/1517 | |
| dc.identifier.contextkey | 798492 | |
| refterms.dateFOA | 2022-08-23T16:35:52Z | |
| html.description.abstract | <p>In an in vitro assay employing reconstituted nuclei, importin 7 (IPO7) has been implicated in nuclear translocation of human immunodeficiency virus type 1 (HIV-1) cDNA. Using RNA interference technology, we inhibited expression of IPO7 by 80 to 95% in primary macrophages and in HeLa cells and monitored their ability to support HIV-1 and simian immunodeficiency virus (SIV) cDNA synthesis, nuclear translocation, and infection efficiency. Marked IPO7 deficiency did not alter the rate or extent of HIV-1 or SIV cDNA synthesis or nuclear translocation. The infection efficiency of HIV-1 was similarly unaltered. Therefore, in natural, nondividing targets of HIV-1, IPO7 may be dispensable for infection.</p> | |
| dc.identifier.submissionpath | oapubs/1517 | |
| dc.contributor.department | Program in Molecular Medicine | |
| dc.source.pages | 11541-6 |
